Hydroxyethyl Starch (HES) Solutions
Mortality and Renal Injury Requiring Renal Replacement Therapy
- In critically ill adult patients, including patients with sepsis, use of hydroxyethyl starch (HES) products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, increases risk of
- Mortality
- Renal replacement therapy
- Do not use HES products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in critically ill adult patients, including patients with sepsis.
Patient Counseling Information
Package Inserts
Updated January 2018